Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 1231 AL 1245

Translation of WNT developmental programs into stem cell replacement strategies for the treatment of Parkinson's disease

Toledo EM, Gyllborg D, Arenas E.

Br J Pharmacol. 2017 Dec;174(24):4716-4724. doi: 10.1111/bph.13871. Epub 2017 Jul 9.

A long-term self-managed handwriting intervention for people with Parkinson's disease: results from the control group of a phase II randomized controlled trial

Collett J, Franssen M, Winward C, Izadi H, Meaney A, Mahmoud W, Bogdanovic M, Tims M, Wade D, Dawes H.

Clin Rehabil. 2017 Dec;31(12):1636-1645. doi: 10.1177/0269215517711232. Epub 2017 May 26.

Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective

Chung SJ, Asgharnejad M, Bauer L, Benitez A, Boroojerdi B, Heidbrede T, Little A, Kim HJ.

Expert Rev Neurother. 2017 Jul;17(7):737-749. doi: 10.1080/14737175.2017.1336087.

Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression

Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB.

Brain. 2017 Jul 1;140(7):1959-1976. doi: 10.1093/brain/awx118.

The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies

Perez-Pardo P, Kliest T, Dodiya HB, Broersen LM, Garssen J, Keshavarzian A, Kraneveld AD.

Eur J Pharmacol. 2017 Dec 15;817:86-95. doi: 10.1016/j.ejphar.2017.05.042. Epub 2017 May 23.

Severe early-onset impulsive compulsive behavior and psychosis in PLA2G6-related juvenile Parkinson's disease

Wirth T, Weibel S, Montaut S, Bigaut K, Rudolf G, Chelly J, Tranchant C, Anheim M.

Parkinsonism Relat Disord. 2017 Aug;41:127-129. doi: 10.1016/j.parkreldis.2017.05.014. Epub 2017 May 19.

Loss of gait control assessed by cognitive-motor dual-tasks: pros and cons in detecting people at risk of developing Alzheimer's and Parkinson's diseases

Belghali M, Chastan N, Cignetti F, Davenne D, Decker LM.

Geroscience. 2017 Jun;39(3):305-329. doi: 10.1007/s11357-017-9977-7. Epub 2017 May 27.

Neurotoxicity of Insecticides

Cassereau J, Ferré M, Chevrollier A, Codron P, Verny C, Homedan C, Lenaers G, Procaccio V, May-Panloup P, Reynier P.

Curr Med Chem. 2017;24(27):2988-3001. doi: 10.2174/0929867324666170526122654.

[New development of diagnosis and treatment for Parkinson's disease]

Orimo S.

Rinsho Shinkeigaku. 2017 Jun 28;57(6):259-273. doi: 10.5692/clinicalneurol.cn-000969. Epub 2017 May 26.

Psychosis in parkinsonism: an unorthodox approach

Onofrj M, Carrozzino D, D'Amico A, Di Giacomo R, Delli Pizzi S, Thomas A, Onofrj V, Taylor JP, Bonanni L.

Neuropsychiatr Dis Treat. 2017 May 16;13:1313-1330. doi: 10.2147/NDT.S116116. eCollection 2017.

Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapy

Sampaio TB, Savall AS, Gutierrez MEZ, Pinton S.

Neural Regen Res. 2017 Apr;12(4):549-557. doi: 10.4103/1673-5374.205084.

Hallmarks of Clinical Aspects of Parkinson's Disease Through Centuries

Bhattacharyya KB.

Int Rev Neurobiol. 2017;132:1-23. doi: 10.1016/bs.irn.2017.01.003. Epub 2017 Mar 1.

Clinical Assessments in Parkinson's Disease: Scales and Monitoring

Bhidayasiri R, Martinez-Martin P.

Int Rev Neurobiol. 2017;132:129-182. doi: 10.1016/bs.irn.2017.01.001. Epub 2017 Feb 16.

Biomarkers of Parkinson's Disease: An Introduction

Titova N, Qamar MA, Chaudhuri KR.

Int Rev Neurobiol. 2017;132:183-196. doi: 10.1016/bs.irn.2017.03.003. Epub 2017 May 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias